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INTRODUCTION
Uncoupling proteins (UCPs) are located within the inner
mitochondrial membrane, and function as proton channels
(1). Whereas mitochondria utilize energy derived from fuel
combustion to create a proton electrochemical gradient across
the mitochondrial inner membrane, UCPs uncouple proton
gradient from ATP synthesis (2). The UCP family has been
characterized in human, and most studies were conducted
on three major members including UCP1 (MIM 113730),
UCP2 (MIM 601693), and UCP3 (MIM 602044) (1). The
expression and activation of UCPs is normally mediated by
the sympathetic nervous system, and is controlled by nore-
pinephrine. Due to their significant roles in energy meta-
bolism, many association studies have been conducted regard-
ing the associations of UCP polymorphisms with metabolic
phenotypes, including metabolic rate, energy expenditure,
exercise efficiency, body mass index (BMI) and diabetes (3-
7). Among UCP family members, UCP1 is expressed pri-
marily in brown adipose tissue (BAT), and has been report-
ed to be responsible for thermogenesis (2).
Recently, the results of some animal studies have provid-
ed some clues regarding the relationship existing between
respiratory uncoupling and blood pressure (8, 9). The uncou-
pling agent, dinitrophenol, has been demonstrated to induce
smooth muscle contraction (10), a hallmark of blood pres-
sure elevation. UCP1 is expressed primarily in brown adi-
pose tissue, and periaotic brown adipose tissue is known to
be present in both rodents and humans, in amounts sufficient
to alter the temperature of the aortic blood (11, 12). Bernal-
Mizrachi et al. demonstrated that UCP1 expression in the
aortic smooth muscle cells of transgenic mice increased the
generation of aortic superoxide, coupled with a 46 mmHg
increase in tail cuff systolic blood pressure (SBP), and a 21
mmHg increase in diastolic blood pressure (DBP) (8). The
relationship between UCP1 and blood pressure regulation
was also suggested by the finding that blood pressure-regu-
latory hormones also modulate the expression of UCP1. Kraus
et al. reported that aldosterone, a mineralcorticoid hormone
that regulates blood pressure, also modulated the expression
of UCP1 in brown adipocytes (13). Porter et al. also deter-
mined that angiotensin II, one of the principal regulators of
blood pressure, increased UCP1 mRNA expression in brown
adipose tissue (14).
Until now, however, the relationship of UCP1 with blood
pressure in human is not clear. In this study, the effects of
genetic polymorphisms of UCP1 on blood pressure were
analyzed in a population consisting of 832 Korean female
subjects. 
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Association of UCP1 Genetic Polymorphisms with Blood Pressure
among Korean Female Subjects
Recent studies have provided some clues with regard to the relationship existing
between uncoupling protein 1 (UCP1) and blood pressure in animal experiments.
In an attempt to determine the genetic polymorphisms that are associated with blood
pressure in humans, we have analyzed genetic polymorphisms in UCP1 gene. In
this study, we assessed the association between UCP1 genotypes and systolic
blood pressure (SBP) and diastolic blood pressure (DBP), in a population comprised
of 832 Korean female subjects, using a general linear model, which was adjusted
for age and body mass index (BMI). Among 4 genetic polymorphisms and the hap-
lotypes constructed from them, haplotype3 of UCP1, UCP1-ht3[GAGA], evidenced
significant associations with SBP (p=0.005) and DBP (p=0.013). However, this
haplotype was not significantly associated with obesity phenotypes, including BMI
or fat mass (p>0.05), thereby suggesting that its association with blood pressure
was independent of obesity phenotypes.
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MATERIALS AND METHODS
Subjects
The 832 female subjects who participated in this study
were recruited from a women’s health and obesity clinic in
the Kirin Medical Foundation (Seoul, Korea). Mean age and
BMI were 27.9 yr and 25.9 kg/m2 respectively. Female sub-
jects over 50 yr old with high possibility of menopause were
only 2.2% of the total subjects (n=18), and exclusion of them
caused no significant effects on the results. Individuals who
were taking anti-hypertensive, anti-hyperlipidemic or anti-
diabetic medications were excluded from this study. Individ-
uals with hypertension but were not taking medicines at the
time of blood pressure measurement were included in the
study, and then they were advised for appropriate medical
care.
The general characteristics of the subjects are listed in Table
1. The SBP and DBP of each of the subjects were measured
after at least 10 min of resting. Body fat mass was measured
via bio-impedance analysis, using a commercial device (Inbody
2.0, Biospace Co., Seoul, Korea). Genomic DNA was obtained
with the informed consent of all participants, and the proto-
cols of this study were approved by the Institutional Review
Board. Genomic DNAs from each subject were extracted
from whole blood, using the AccuprepTM Genomic DNA
Extraction Kit (Bioneer Co., Daejeon, Korea), in accordance
with the manufacturer’s instructions.
Genotyping
The genotyping of genetic polymorphisms was conduct-
ed via the TaqMan method. Primer Express (Applied Biosys-
tems, Foster City, CA, U.S.A.) was employed in the design
of both the polymerase chain reaction (PCR) primers and the
TaqMan probes. The relevant primer information was listed
in Table 2. One allelic probe was labeled with FAM dye, and
the other with VIC dye. PCRs were run in TaqMan Univer-
sal Master Mix (Applied Biosystems) with PCR primer con-
centrations of 900 nM and TaqMan probe concentrations of
200 nM. Reactions were conducted in a 384-well format, in
a total reaction volume of 5 μ L, using 20 ng of genomic DNA.
The plates then were positioned in a thermal cycler (PE 9700,
Applied Biosystems) and heated for 2 min at 50℃and 10 min
at 95℃, followed by 40 cycles of 95℃ for 15 sec and 60℃
for 1 min. The assay mixtures were then transferred to a Prism
7900HT (Applied Biosystems), in which the fluorescence
intensity in each well of the plate was determined. 
Statistical analysis 
Hardy-Weinberg equilibrium tests were utilized in order
to determine whether or not individual genetic polymor-
phisms were in equilibrium at each locus within the popu-
lation. |D’| and r2 were evaluated in order to measure link-
age disequilibrium between all single nucleotide polymor-
phism (SNP) loci (15), and haplotypes and their frequencies
Variables N Mean±SD
Age (yr) 832 27.88±7.80
Weight (kg) 832 66.86±11.74
BMI (kg/m
2) 832 25.89±4.27
SBP 832 115.38±12.84
DBP 832 72.35±10.23
Table 1. General characteristics of study subjects
Gene Loci Sequence
UCP1 -3954A>G Forward CCCAGTGGTGGCTAATGAGAG
Reverse GGAGAGGGTGGTATCCCCAA
Probe-1 (VIC) GTTTGATCAAGTGCATT
Probe-2 (FAM) GTTTGATCGAGTGCATT
-1766A>G Forward TCCACATCTAATCATTCATAAAGCTGTATTGT
Reverse TTCATGTTATCACCTGTGTAGTGCTT
Probe-1 (VIC) CATTTATGTGAGAGCACTT
Probe-2 (FAM) ATTTATGTGAGGGCACTT
+940A>G (A64T) Forward CCGACGTCCAGTGTTATTAGGTAT
Reverse AGTTTCATCCGCCCTTCTGTTTT
Probe-1 (VIC) AACAATCACCGCTGTGGT
Probe-2 (FAM) AACAATCACCACTGTGGT
+6537A>T (M229L) Forward GGCTCTTATCGCTGGATTTTGC
Reverse GTCCTGGTGGAGAATTAATAAATCTGGTT
Probe-1 (VIC) CAACAGCTATGTCCTC
Probe-2 (FAM) CAACAGCTTTGTCCTC
Table 2. Amplifying primers and taqman probes for genotyping of UCP1 polymorphisms
UCP1, uncoupling protein 1.
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic
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were inferred using the algorithm, HapAnalyzer (http://hap.
ngri.go.kr). Association analyses were performed using gen-
eral linear model procedures, in which were included the
effects of the UCP1 genetic polymorphism, age, and BMI.
Age and BMI-adjusted analysis of covariance (ANCOVA)
was conducted in order to assess the independent effects of
the UCP1 polymorphisms on blood pressure. Statistical sig-
nificance was established at a level of p<0.05. All analyses
were conducted using the SAS system for windows, version
8.2 (SAS Korea, Seoul, Korea).
RESULTS
In this study, genetic polymorphisms in UCP1 gene were
evaluated with regard to their association with blood pres-
sure in a population composed of 832 Korean women. Sixty
five male subjects were also recruited, and their numbers
were not enough for parametric statistical analyses. Because
the number of male subjects was less than 8% of the num-
ber of female subjects, the statistical analyses were confined
to female subjects for the controlling of the sex-related phys-
iological factors. Inclusion of male subjects in statistical anal-
yses showed similar results (data not shown). 
Among the 37 UCP1 polymorphisms listed in the NCBI
database (http://www.ncbi.nlm.nih.gov/projects/SNP/), four
SNP found in promoter and exon regions were selected for
genotyping of all 832 subjects. The gene map of UCP1 and
locations of the selected SNPs are shown in Fig. 1A, and char-
acteristics of them were summarized in Table 3. The geno-
typic distributions of four selected SNPs were all determined
to be in Hardy-Weinberg equilibrium (HWE) (p>0.05). As
shown in Fig. 1B, four common haplotypes with frequencies
more than 0.05 were constructed from four selected SNPs
of UCP1. Among them, UCP1-ht1[AAGA] was tagged by
-3954A>G with a frequency in excess of 95%. Likewise,
UCP1-ht2[GGGA] and UCP1-ht4[GAAT] were tagged
almost completely by -1766A>G and +6537A>T, respec-
tively. These tagged haplotypes were not analyzed further,
as their effects were almost identical to their tagging SNPs. 
Four SNPs and UCP1-ht3[GAGA]haplotype were further
analyzed with regard to their association with SBP and DBP
after adjusting for age and BMI in the 832 Korean female
subjects. UCP1-ht3 evidenced a significant association with
Ex1
+1
Ex2
Map of UCP1 on chromosome 4q28-q31
Haplotypes of UCP1
-3954A>G (0.49)
-1766A>G (0.27)
+940A>G (A64T) (0.07)
+6537A>T (M229L) (0.11)
Ex3,4 Ex5 Ex6 A
B
Hap. Freq.
-3954A>G
-1766A>G
+940A>G (A64T)
+6537A>T (M229L)
htl A A G A 0.480
ht2 G G G A 0.242
ht3 G A G A 0.166
ht4 G A A T 0.065
Other
(1) --- -0.047
Linkage among UCP1 polymorphisms
C
r
2 +6537A>T 
(M229L)
+940A>G 
(A64T)
-1766A>G -3954A>G
lD’l
-3954A>G - 0.91 0.66 0.74
-1766A>G 0.3 - 0.93 0.57
+940A>G (A64T) 0.03 0.02 - 1
+6537A>T (M229L) 0.06 0.01 0.72 -
Fig. 1. Genetic polymorphisms of the UCP1. (A) Gene map of UCP1 on chromosome 4q28-q31 (Ref. Genome Seq. NT_016354). Coding
exons are marked by black blocks and 5’ UTRs are marked by white blocks. (B) Common haplotypes constructed from four SNPs. (C)
Linkage disequilibrium coefficients among four SNPs. 
Gene Locus Position HWE rs#
Amino acid 
change
Minor allele 
frequency
UCP1 -3954A>G Promoter 0.49 0.98 rs1800592
-1766A>G Promoter 0.27 0.99 rs3811791
+940A>G (A64T) Exon2 A64T 0.07 0.55 rs45539933
+6537A>T (M229L) Exon5 M229L 0.11 0.91 rs2270565
Table 3. Characteristic of polymorphisms used for genotyping of the whole subjects
HWE, Hardy-weinberg equilibrium; UCP1, uncoupling protein 1.UCP1 Genetic Polymorphism and Blood Pressure 779
SBP (Table 4). The SBP distributions were as follows: 114.63
±0.50 mmHg (n=553) among UCP1-ht3 non-carriers;
117.36±0.75 mmHg (n=248) among heterozygotes; and
112.98±2.11 mmHg (n=31) among homozygote (p=0.005
in codominant model). Similar associations were determined
to exist between UCP1-ht3 and DBP. The DBP distributions
were as follows: 71.84±0.42 mmHg among UCP1-ht3 non-
carriers; 73.80±0.62 mmHg among heterozygotes; and
69.98±1.77 mmHg among homozygote (p=0.013 in the
codominant model) (Table 5). As five independent statisti-
cal tests were conducted in Table 4, the significance level is
0.05/5=0.01 after Bonferroni correction, which is the most
conservative method of multiple comparison correction (16).
The results showed that the association of UCP1-ht3 with
SBP is highly significant: significant even after multiple com-
parison correction (p<0.01). 
As blood pressure was closely associated with obesity phe-
notypes, the observed associations between UCP1-ht3 and
blood pressure might have been mediated by its effects on
obesity phenotypes, in spite of the fact that BMI had been
adjusted for in the statistical analyses. In order to ascertain
this, the BMI and body fat mass of all subjects were com-
pared with regard to UCP1-ht3 (Table 6). Our findings indi-
cated that UCP1-ht3 had no statistically significant effect on
either BMI or fat mass among the subjects. This suggests
that the association of the UCP1-ht3 with blood pressure
may be independent on its effects on obesity phenotypes.
DISCUSSION
The association pattern of UCP1-ht3 with blood pressure
Gene R/R C/R C/C Locus
p
Co-dominant Dominant Recessive
UCP1 -3954A>G 216 (71.55±0.67 ) 407 (73.25±0.49) 209 (71.40±0.68) 0.035 0.169 0.113
-1766A>G 458 (72.51±0.46) 308 (72.25±0.56) 63 (71.97±1.25) 0.885 0.654 0.733
+940A>G  (A64T) 707 (72.43±0.37) 111 (71.42±0.94) 5 (70.84±4.41) 0.576 0.742 0.297
+6537A>T (M229L) 674 (72.59±0.38) 149 (71.59±0.81) 8 (69.75±3.50) 0.398 0.208 0.448
UCP1-ht3 553 (71.84±0.42) 248 (73.80±0.62) 31 (69.98±1.77) 0.013 0.033 0.173
Table 5. Analyses of covariance of UCP polymorphisms with DBP controlling for age and BMI among Korean female subjects
C/C, C/R, and R/R represent homozygotes for the common allele, and heterozygotes and homozygotes for the rare allele, respectively. Genotype and hap-
lotype distributions (mean±SE), and p values of three alternative models (co-dominant, dominant, and recessive) of analysis of covariance (ANCOVA) are
shown. pvalues less than 0.05 were marked by bold fonts.
UCP1, uncoupling protein; SBP, systolic blood pressure; BMI, body mass index.
Gene R/R C/R C/C Locus
p
Co-dominant Dominant Recessive
UCP1 -3954A>G 216 (113.97±0.80) 406 (116.08±0.59) 209 (115.48±0.82) 0.058 0.042 0.883
-1766A>G 458 (115.27±0.56) 307 (115.73±0.68) 63 (114.77±1.49) 0.794 0.727 0.660
+940A>G  (A64T) 706 (115.34±0.45) 111 (115.20±1.13) 5 (113.56±5.31) 0.940 0.740 0.856
+6537A>T (M229L) 673 (115.47±0.46) 149 (115.33±0.97) 8 (112.29±4.19) 0.749 0.773 0.454
UCP1-ht3 553 (114.63±0.50) 248 (117.36±0.75) 31 (112.98±2.11) 0.005 0.010 0.249 
Table 4. Analyses of covariance of UCP1 polymorphisms with SBP controlling for age and BMI among Korean female subjects
C/C, C/R, and R/R represent homozygotes for the common allele, and heterozygotes and homozygotes for the rare allele, respectively. Genotype and hap-
lotype distributions (mean±SE), and p values of three alternative models (co-dominant, dominant, and recessive) of analysis of covariance (ANCOVA) are
shown. pvalues less than 0.05 were marked by bold fonts.
UCP1, uncoupling protein; SBP, systolic blood pressure; BMI, body mass index.
Gene R/R C/R C/C Phenotype
p
Co-dominant Dominant Recessive
UCP1-ht3 BMI (kg/m
2) 553 (26.04±0.17) 248 (25.64±0.24) 31 (25.16±0.77) 0.242 0.129 0.263
Fat mass (kg) 553 (23.72±0.33) 248 (22.87±0.45) 31 (22.24±1.47) 0.224 0.095 0.374
Table 6. Analyses of covariance of UCP1-ht3 with obesity phenotypes controlling for age among Korean female subjects
C/C, C/R, and R/R represent homozygotes for the common allele, and heterozygotes and homozygotes for the rare allele, respectively. Haplotype distribu-
tions (mean±SE), and pvalues of three alternative models (co-dominant, dominant, and recessive) of analysis of covariance (ANCOVA) are shown.
BMI, body mass index; UCP1, uncoupling protein 1. 780 M.H. Cha, B.K. Kang, D. Suh, et al.
can not be explained by classical mendelian inheritance,
because heterozyote showed higher blood pressure than
UCP1-ht3 homozygote. Another form of inheritance was
suggested which is neither dominant nor recessive and in
which only heterozygote is affected (17). In this situation,
homozygosity for the normal allele and the mutant allele
give a normal phenotype. Only heterozygote produces an
abnormal phenotype because the two alleles, when present
together, interact to produce a harmful effect. Pedigree stud-
ies provided possible evidences for the harmful interaction
of two alleles in human diseases (18). UCP1 polymorphism
study conducted on Japanese males suggested similar two
allele interaction. It was reported that AG heterozygote of
the A-3826G polymorphism of UCP1 has higher risk than
AA and GG homozygote suggesting a harmful interaction
of two alleles in UCP1 heterozygote (19). Even though more
study should be conducted to get clear evidence of the two
allele interaction, our results suggest that heterozygosity of
UCP1-ht3 haplotype was associated with elevated blood pres-
sure in Korea female subjects.
The findings of this study should be interpreted within
the context of its limitations. The subjects of this study were
young females, and our findings might not be appropriate
for extrapolation to general population. However, the sig-
nificant associations observed in this study provide some
evidence of the involvement of UCP1 in the blood pressure
of human.
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